Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Epien Medical Inc. currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This action is handled by 1 distinct examiner, VIGIL, TORIANA NICHOLE, who is the busiest examiner for the portfolio with 1 pending office action. The prosecution is focused within 1 distinct art unit, which indicates a specific and concentrated area of interest for the company. Having 1 pending office action allows the applicant to dedicate full attention to the requirements of this single case. VIGIL, TORIANA NICHOLE is the sole examiner responsible for reviewing the company's current patent application.
The concentration in 1 distinct art unit simplifies the prosecution process by providing a single set of examination standards. This lack of diversity in examiners or art units means the company does not have to manage conflicting feedback from different parts of the office. Because 1 distinct examiner is involved, the applicant can focus on building a clear and persuasive case for VIGIL, TORIANA NICHOLE. The Biotechnology & Pharmaceuticals field often involves rigorous examination, but the presence of only 1 pending office action makes the workload manageable. This streamlined structure allows for a highly focused and efficient prosecution strategy.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VIGIL, TORIANA NICHOLE | 1 | 53.1% | +24.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18361283 | WOUND CARE AND METHOD FOR PREVENTING WOUND INFECTION | VIGIL, TORIANA NICHOLE | 24d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18361283 | WOUND CARE AND METHOD FOR PREVENTING WOUND INFECTION | VIGIL, TORIANA NICHOLE | 24d overdue |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18361283 | WOUND CARE AND METHOD FOR PREVENTING WOUND INFECTION | VIGIL, TORIANA NICHOLE | 1612 | §103§112 | Final Rejection | 24d overdue | Pending | Jul 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial